Schall, Brown & Schwartz LLP said it is investigating AdaptHealth Corp. for potential securities law violations after the company reported Q2 2026 results on August 4, 2026 that missed consensus earnings-per-share estimates and cut full-year guidance by a significant amount. AdaptHealth shares fell by more than 38% the same day, a move that often draws scrutiny over whether prior disclosures accurately reflected business conditions and outlook. The law firm said the review is focused on whether the company issued false or misleading statements or failed to disclose information material to investors.